FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2040254139> ?p ?o ?g. }

• W2040254139 endingPage "635" @default.
• W2040254139 startingPage "628" @default.
• W2040254139 abstract "Sustained-release (SR) alprazolam may facilitate compliance with oral benzodiazepine treatment of panic disorders that currently requires doses administered three or four times daily. To compare the pharmacokinetic, psychomotor performance, and subjective effects of alprazolam SR (1.5 mg), bromazepam (3 mg taken three times daily), and lorazepam (1 mg taken three times daily), 13 male volunteers (aged 20-45 years) randomly received on four separate occasions one of these medications or placebo. Once before and 11 times after drug administration, the subjects were tested using psychomotor performance tests (manual tracking and digit-symbol substitution test [DSST]) and computerized questionnaires (such as the Tufts University Benzodiazepine Scale [TUBS], the Addiction Research Center Inventory, and the visual analog scales) to determine the subjective effects of the drugs. Blood samples for the determination of the plasma levels of the drugs were collected before and 17 times after the drug was administered. A peak plateau of plasma alprazolam began approximately 6 hours after the dose, which was later than the initial peaks for lorazepam and bromazepam (1-2 hours after the dose). Once this plateau had begun, alprazolam SR sustained that concentration better than did the other two formulations. Of the 10 measures on which the response averaged for the first 14 hours differed among drugs (p < 0.05), bromazepam differed from placebo on two measures, lorazepam on four (including DSST Performance and TUBS Sedation), and alprazolam SR on nine (including all four affected by lorazepam). Lorazepam and alprazolam, but not bromazepam, produced significantly more sedation than placebo. The doses of the three drugs were not equipotent in sedation and mood effects. None of the drugs tested differed from placebo on measures relevant to abuse liability." @default.
• W2040254139 created "2016-06-24" @default.
• W2040254139 creator A5005698332 @default.
• W2040254139 creator A5013791504 @default.
• W2040254139 creator A5021337912 @default.
• W2040254139 creator A5059129053 @default.
• W2040254139 creator A5060379814 @default.
• W2040254139 creator A5062487017 @default.
• W2040254139 creator A5087737186 @default.
• W2040254139 date "2000-12-01" @default.
• W2040254139 modified "2023-09-25" @default.
• W2040254139 title "A Comparative Pharmacokinetic and Dynamic Evaluation of Alprazolam Sustained-Release, Bromazepam, and Lorazepam" @default.
• W2040254139 cites W1977967074 @default.
• W2040254139 cites W1987073422 @default.
• W2040254139 cites W1988595085 @default.
• W2040254139 cites W2003456658 @default.
• W2040254139 cites W2021516828 @default.
• W2040254139 cites W2047501424 @default.
• W2040254139 cites W2060776587 @default.
• W2040254139 cites W2062804852 @default.
• W2040254139 cites W2063277401 @default.
• W2040254139 cites W2066802630 @default.
• W2040254139 cites W2089961803 @default.
• W2040254139 cites W2094468003 @default.
• W2040254139 cites W2111775018 @default.
• W2040254139 cites W2157220260 @default.
• W2040254139 cites W2325705295 @default.
• W2040254139 cites W36420567 @default.
• W2040254139 cites W4322694688 @default.
• W2040254139 doi "https://doi.org/10.1097/00004714-200012000-00008" @default.
• W2040254139 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11106134" @default.
• W2040254139 hasPublicationYear "2000" @default.
• W2040254139 type Work @default.
• W2040254139 sameAs 2040254139 @default.
• W2040254139 citedByCount "19" @default.
• W2040254139 countsByYear W20402541392012 @default.
• W2040254139 countsByYear W20402541392013 @default.
• W2040254139 countsByYear W20402541392015 @default.
• W2040254139 countsByYear W20402541392016 @default.
• W2040254139 countsByYear W20402541392021 @default.
• W2040254139 crossrefType "journal-article" @default.
• W2040254139 hasAuthorship W2040254139A5005698332 @default.
• W2040254139 hasAuthorship W2040254139A5013791504 @default.
• W2040254139 hasAuthorship W2040254139A5021337912 @default.
• W2040254139 hasAuthorship W2040254139A5059129053 @default.
• W2040254139 hasAuthorship W2040254139A5060379814 @default.
• W2040254139 hasAuthorship W2040254139A5062487017 @default.
• W2040254139 hasAuthorship W2040254139A5087737186 @default.
• W2040254139 hasConcept C112705442 @default.
• W2040254139 hasConcept C118552586 @default.
• W2040254139 hasConcept C126322002 @default.
• W2040254139 hasConcept C142724271 @default.
• W2040254139 hasConcept C15744967 @default.
• W2040254139 hasConcept C170493617 @default.
• W2040254139 hasConcept C204787440 @default.
• W2040254139 hasConcept C27081682 @default.
• W2040254139 hasConcept C2776615572 @default.
• W2040254139 hasConcept C2776814716 @default.
• W2040254139 hasConcept C2777196872 @default.
• W2040254139 hasConcept C2777765862 @default.
• W2040254139 hasConcept C2778173252 @default.
• W2040254139 hasConcept C2778519950 @default.
• W2040254139 hasConcept C2779706987 @default.
• W2040254139 hasConcept C2781006864 @default.
• W2040254139 hasConcept C42219234 @default.
• W2040254139 hasConcept C558461103 @default.
• W2040254139 hasConcept C71924100 @default.
• W2040254139 hasConcept C98274493 @default.
• W2040254139 hasConceptScore W2040254139C112705442 @default.
• W2040254139 hasConceptScore W2040254139C118552586 @default.
• W2040254139 hasConceptScore W2040254139C126322002 @default.
• W2040254139 hasConceptScore W2040254139C142724271 @default.
• W2040254139 hasConceptScore W2040254139C15744967 @default.
• W2040254139 hasConceptScore W2040254139C170493617 @default.
• W2040254139 hasConceptScore W2040254139C204787440 @default.
• W2040254139 hasConceptScore W2040254139C27081682 @default.
• W2040254139 hasConceptScore W2040254139C2776615572 @default.
• W2040254139 hasConceptScore W2040254139C2776814716 @default.
• W2040254139 hasConceptScore W2040254139C2777196872 @default.
• W2040254139 hasConceptScore W2040254139C2777765862 @default.
• W2040254139 hasConceptScore W2040254139C2778173252 @default.
• W2040254139 hasConceptScore W2040254139C2778519950 @default.
• W2040254139 hasConceptScore W2040254139C2779706987 @default.
• W2040254139 hasConceptScore W2040254139C2781006864 @default.
• W2040254139 hasConceptScore W2040254139C42219234 @default.
• W2040254139 hasConceptScore W2040254139C558461103 @default.
• W2040254139 hasConceptScore W2040254139C71924100 @default.
• W2040254139 hasConceptScore W2040254139C98274493 @default.
• W2040254139 hasIssue "6" @default.
• W2040254139 hasLocation W20402541391 @default.
• W2040254139 hasLocation W20402541392 @default.
• W2040254139 hasOpenAccess W2040254139 @default.
• W2040254139 hasPrimaryLocation W20402541391 @default.
• W2040254139 hasRelatedWork W117263207 @default.
• W2040254139 hasRelatedWork W188128380 @default.
• W2040254139 hasRelatedWork W1974706015 @default.
• W2040254139 hasRelatedWork W2040254139 @default.
• W2040254139 hasRelatedWork W2062090682 @default.

• next